Compare KE Holdings Inc (BEKE) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KE Holdings Inc vs Heron Therapeutics Inc — how do they compare? KE Holdings Inc trades at $17.22 (market cap $18.92B), while Heron Therapeutics Inc trades at $0.31 (market cap $61.47M). The key difference: KE Holdings Inc is far larger — about 307.8× Heron Therapeutics Inc's market cap, and KE Holdings Inc pays a 1.63% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| BEKE | HRTX | |
|---|---|---|
Market Cap | $18.92B | $61.47M |
Sector | Technology | Health |
52-Week High | $20.36 | $1.49 |
52-Week Low | $14.26 | $0.32 |
Enterprise Value | $14.66B | $168.21M |
Dividend Yield | 1.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About KE Holdings Inc
KE Holdings (Beike) is China’s leading platform for housing transactions and services. It operates the Lianjia brand and uses data-driven technology to facilitate home sales, rentals, and home renovation services.
Read more on BEKE →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
